We would expect most companies to have some institutions on the register, especially if they are growing. ZAGG already has institutions on the share registry. Indeed, they own a respectable stake in the company.
This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'.
When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see ZAGG's historic earnings and revenue below, but keep in mind there's always more to the story.
Hedge funds don't have many shares in ZAGG. The company's largest shareholder is Dimensional Fund Advisors L. In comparison, the second and third largest shareholders hold about 5. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is a little analyst coverage of the stock, but not much.
So there is room for it to gain more coverage. The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Insider ownership is positive when it signals leadership are thinking like the true owners of the company.
However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances. Execute Advice. X Recommendations are not available for this entity. Please try other suggestions below. If you believe the indicator you are trying to look up is valid please let us know and we will check it out.
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations.
Fix portfolios for free. Did You Try This Idea? Run Chemicals Thematic Idea Now. Fama and French focuses on testing asset pricing under different economic assumptions. Chemicals theme has 60 constituents. Check out Your Current Watchlist. Note that the ZAGG Inc information on this page should be used as a complementary analysis to other ZAGG's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio.
Not to mention it can be expensive. Some of the most well-known names like Amazon and Alphabet can put you out thousands of dollars for just a single share. Using the TipRanks database, we were able to pinpoint two stocks with massive u. The IRS makes inflation adjustments yearly, but this year they coincided with hot October inflation data. The media giant stumbles after its latest quarterly results, but don't sleep on the turnaround taking place at the happiest place on Earth. It also announced that its founder and CEO Piotr Szulczewski would step down next February but remain on the company's board.
When Wish went public last December, it served over million monthly active users MAUs with its discount marketplace, which mainly enabled Chinese merchants to sell their products to overseas buyers. It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks Nearly a week since it reported estimate-crushing earnings for the fiscal third quarter of , shares of rare earth metals miner MP Materials NYSE: MP are marching higher on Thursday, rising 9.
MP Materials may not be the lowest-cost miner of rare earth metals, admitted Jefferies this morning in a note covered by StreetInsider. Investors have some reason to hope that Congress might pass a marijuana legalization bill sooner than previously expected. The recent spin-off of its managed infrastructure business into a company called Kyndryl NYSE: KD removes a noncore business from its balance sheet.
Also, management promised that the two companies would maintain the current combined dividend. For most of the past two years, all the focus has been on the coronavirus, but these biotechs have big plans to develop inoculations against other diseases, too. The company faces significant headwinds from the economic reopening, which has pushed its audience away from some of its core use cases, including cooking, gardening, and home decor.
This shift is one reason the company is struggling with user growth. A bevy of Wall Street analysts followed up by lowering their price targets for the stock, adding to today's pain. According to The Fly, four analysts lowered their price targets for the stock as a result of third-quarter results. Dow 30 36, Thu, Nov 11, Golden Star Signal. Get access to Golden Star list now! Stock Podcast. Click the Predict button to answer the prediction request. Test your skills and become famous.
Best predictor for any stock is listed at the stock pages.
0コメント